Catalyst
Slingshot members are tracking this event:
Neruocrine (NBIX) Phase 3 KINECT 3 Data Evaluating Ingrezza in Tardive Dyskinesia Published in the American Journal of Psychiatry
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| NBIX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 21, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3, Kinect 3, Ingrezza, Tardive Dyskinesia, American Journal Of Psychiatry
